List of insiders holdings for LEXICON PHARMACEUTICALS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Artal Participations S.a r.l. Director 10% Owner | 2024-12-16 19:00:08 | 136,180,481 0 | 136,180,481 | Form 3 |
| Artal International S.C.A. Wittouck Amaury Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Invus Public Equities L.P. Invus L.P. Invus Public Equities Advisors LLC Invus Advisors L.L.C. Director 10% Owner | 2024-12-09 21:33:20 | 136,180,481 0 | 136,180,481 | Form 13D |
| Invus Public Equities L.P. Artal Treasury Ltd Invus L.P. Invus Public Equities Advisors LLC Invus Advisors L.L.C. Director 10% Owner | 2024-12-09 21:33:20 | 136,180,481 0 | 136,180,481 | Form 13D |
| Artal International S.C.A. Minne Pascal Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Director 10% Owner | 2020-12-17 14:43:18 | 0 71,178,364 | 71,178,364 | Form 4 |
| Siren L.L.C. Invus Global Management LLC Director 10% Owner | 2024-07-29 17:31:42 | 0 38,918,903 | 38,918,903 | Form 3 |
| MCNAIR ROBERT C 10% Owner | 2003-08-08 16:21:09 | 5,949,400 0 | 5,949,400 | Form 13D |
| Invus US Partners LLC Ulys L.L.C. DEBBANE RAYMOND Director 10% Owner | 2022-08-09 16:48:13 | 331,545 5,451,204 | 5,782,749 | Form 4 |
| Invus C.V. Director 10% Owner | 2021-01-05 21:21:12 | 4,321,214 0 | 4,321,214 | Form 4 |
| SANDS ARTHUR T President & CEO | 2014-03-03 18:20:20 | 1,236,579 877,500 | 2,114,079 | Form 4 |
| Exton Michael Chief Executive Officer | 2024-07-08 17:27:00 | 1,675,000 0 | 1,675,000 | Form 4 |
| COATS LONNEL Chief Executive Officer | 2024-02-29 16:26:53 | 1,430,198 0 | 1,430,198 | Form 4 |
| Garner Thomas SVP, Chief Commercial Officer | 2024-02-12 16:14:04 | 454,260 0 | 454,260 | Form 4 |
| ZAMBROWICZ BRIAN P EVP, Chief Scientific Officer | 2014-03-03 18:16:40 | 402,953 0 | 402,953 | Form 4 |
| DeFrancesco Lisa VP, IR and Corp Strategy | 2024-10-07 16:58:38 | 378,040 0 | 378,040 | Form 3 |
| MAIN ALAN J EVP, Innov & Chem Sciences | 2024-02-29 16:30:47 | 347,198 0 | 347,198 | Form 4 |
| WADE JEFFREY L President and COO | 2024-07-08 17:27:46 | 307,000 0 | 307,000 | Form 4 |
| Crum Brian T SVP, General Counsel & Secr. | 2024-02-29 16:27:54 | 270,507 0 | 270,507 | Form 4 |
| Kassler-Taub Kenneth B. SVP, Regulatory & QA | 2024-02-29 16:29:48 | 255,742 0 | 255,742 | Form 4 |
| BROWN PHILIP M SVP, Clinical Development | 2010-02-17 17:12:29 | 253,606 0 | 253,606 | Form 4 |
| BANSAL AJAY EVP Corp Dev and CFO | 2009-06-02 17:44:48 | 250,000 0 | 250,000 | Form 4 |
| TYLE PRAVEEN EVP, R&D | 2021-03-02 17:00:45 | 204,771 0 | 204,771 | Form 4 |
| Corrigan Brian SVP, Regulatory & QA | 2024-08-12 08:40:16 | 200,000 0 | 200,000 | Form 4 |
| RIGGS RANDALL B SVP, Corp Licensing | 2004-02-25 16:13:19 | 192,500 0 | 192,500 | Form 4 |
| Cheung Ivan Director | 2024-12-02 17:41:59 | 186,685 0 | 186,685 | Form 4 |
| GREGORY JULIA P EVP and CFO | 2008-02-11 18:05:27 | 150,000 0 | 150,000 | Form 4 |
| Granowitz Craig B SVP, Chief Medical Officer | 2024-02-29 16:28:56 | 147,123 0 | 147,123 | Form 4 |
| McDermott Wendy VP, Human Resources | 2024-02-29 16:31:43 | 127,030 0 | 127,030 | Form 4 |
| Tessmer James F VP, Finance & Accounting | 2021-03-16 19:45:56 | 122,746 0 | 122,746 | Form 4 |
| Seth Kiernan VP, Chief Commercial Officer | 2023-03-01 16:55:29 | 104,350 0 | 104,350 | Form 4 |
| HOWSON TAMAR D EVP of Bus Dev | 2008-02-11 18:05:30 | 100,000 0 | 100,000 | Form 4 |
| Alexander Kristen VP, Finance and Accounting | 2024-02-29 16:33:17 | 90,270 0 | 90,270 | Form 4 |
| Lapuerta Pablo EVP and CMO | 2020-04-24 17:02:57 | 85,719 0 | 85,719 | Form 4 |
| Tragash Steven Alan VP, Corporate Affairs | 2010-02-17 18:06:17 | 85,500 0 | 85,500 | Form 4 |
| Amouyal Philippe Director | 2024-05-13 16:00:44 | 81,716 0 | 81,716 | Form 4 |
| BARKER SAM L Director | 2024-05-13 16:01:32 | 81,716 0 | 81,716 | Form 4 |
| DEBBANE RAYMOND Director | 2024-05-13 16:02:19 | 81,716 0 | 81,716 | Form 4 |
| LEFKOWITZ ROBERT J MD Director | 2024-05-13 16:03:08 | 81,716 0 | 81,716 | Form 4 |
| SOBECKI CHRISTOPHER J Director | 2024-05-13 16:03:48 | 81,716 0 | 81,716 | Form 4 |
| Sullivan Diane E. Director | 2024-05-13 16:04:41 | 81,716 0 | 81,716 | Form 4 |
| Swain Judith L Director | 2024-05-13 16:05:26 | 81,716 0 | 81,716 | Form 4 |
| ISHIMOTO LANCE K SVP, Intellectual Property | 2008-02-11 18:05:33 | 80,000 0 | 80,000 | Form 4 |
| PERSON CHRISTOPHE VP Informatics | 2004-01-13 17:01:48 | 75,900 0 | 75,900 | Form 4 |
| SCHAFER CAROL VP Finance - Communications | 2003-12-10 15:01:46 | 61,000 0 | 61,000 | Form 3 |
| Santini Alexander A EVP and CCO | 2020-04-24 17:12:22 | 55,584 0 | 55,584 | Form 4 |
| PIGGOTT JAMES R PHD SVP of Pharm Bio | 2008-02-11 18:05:40 | 50,000 0 | 50,000 | Form 4 |
| NORTHCOTT JOHN VP, Marketing, Comm Strategy | 2015-03-03 16:08:14 | 41,985 0 | 41,985 | Form 4 |
| NIES ALAN S Director | 2023-05-22 16:05:20 | 41,046 0 | 41,046 | Form 4 |
| Palantoni Frank Director | 2023-05-22 16:06:07 | 40,332 0 | 40,332 | Form 4 |
| COLBERT WALTER F SVP, HR and Corp Serv | 2007-02-15 16:40:13 | 40,000 0 | 40,000 | Form 4 |
| ROSE CLAYTON STUART Director | 2007-06-27 16:34:13 | 25,000 0 | 25,000 | Form 4 |
| Mills Barry Director | 2007-04-27 16:35:38 | 10,000 0 | 10,000 | Form 4 |
| CLOHERTY PATRICIA M Director | 2006-04-28 17:58:27 | 10,000 0 | 10,000 | Form 4 |
| Wiltsey Kathleen M Director | 2009-04-27 16:40:25 | 10,000 0 | 10,000 | Form 4 |
| CASKEY C THOMAS Director | 2005-10-17 17:52:09 | 6,300 200 | 6,500 | Form 4 |